Maryland State Retirement & Pension System’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,656
Closed -$68.4K 1432
2026
Q1
$68.4K Hold
15,656
﹤0.01% 1348
2025
Q4
$79.1K Buy
+15,656
New +$72.7K ﹤0.01% 1361
2025
Q2
Sell
-31,322
Closed -$126K 1492
2025
Q1
$126K Sell
31,322
-4,648
-13% -$24.1K ﹤0.01% 1441
2024
Q4
$233K Hold
35,970
0.01% 1447
2024
Q3
$199K Buy
35,970
+2,558
+8% +$14.5K ﹤0.01% 1499
2024
Q2
$186K Sell
33,412
-2,550
-7% -$15.3K ﹤0.01% 1519
2024
Q1
$214K Hold
35,962
﹤0.01% 1479
2023
Q4
$328K Sell
35,962
-699
-2% -$4.4K 0.01% 1363
2023
Q3
$202K Buy
36,661
+5,476
+18% +$43.9K ﹤0.01% 1494
2023
Q2
$266K Buy
+31,185
New +$280K 0.01% 1435

Other funds holding CTKB

Maryland State Retirement & Pension System's CTKB Position: Q2 2026 in Review

Maryland State Retirement & Pension System sold out of Cytek Biosciences (CTKB) in Q2 2026, closing a stake of 15,656 shares — an estimated $68.4K sold.

Maryland State Retirement & Pension System first reported a position in CTKB in Q2 2023 and held it in 10 quarters. The position peaked at $328K in Q4 2023. 155 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Maryland State Retirement & Pension System reported no remaining Cytek Biosciences position as of Q2 2026 after selling out during the quarter.
  • Maryland State Retirement & Pension System sold 15,656 Cytek Biosciences shares in Q2 2026, an estimated $68.4K.
  • Maryland State Retirement & Pension System first reported a position in Cytek Biosciences in Q2 2023 and held it in 10 quarters.
  • Maryland State Retirement & Pension System's Cytek Biosciences position peaked at $328K in Q4 2023.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.